Pfizer will have to pay rebates to Medicare for five drugs under Biden plan to lower Rx costs
Publishing timestamp: 2023-03-15 10:04:39
Summary
Five of Pfizer's drugs will cost less for Medicare recipients starting next month as part of President Joe Biden's plan to lower prescription drug costs. These drugs are among the first set of 27 Part B prescription drugs that will be subject to Medicare inflation rebates starting April 1st. The savings stem from the Inflation Reduction Act, which congressional Democrats passed last August. The announcement is also part of Biden's broader push to reduce healthcare costs for Americans amid stubbornly high inflation.
Sentiment: NEUTRAL
Tickers: PFE,
Keywords: breaking news: business, biotech and pharmaceuticals, joe biden, business news, pharmaceuticals, politics, breaking news, health care industry, pfizer inc, biotechnology, business,